LYMPHVASCULAR SPACE INVOLVEMENT - A PROGNOSTIC INDICATOR IN ENDOMETRIAL ADENOCARCINOMA

被引:78
|
作者
GAL, D
RECIO, FO
ZAMUROVIC, D
TANCER, ML
机构
[1] SUNY HLTH SCI CTR BROOKLYN,BROOKLYN,NY
[2] MAIMONIDES HOSP,DEPT GYNECOL ONCOL,BROOKLYN,NY 11219
[3] MAIMONIDES HOSP,DEPT PATHOL,BROOKLYN,NY 11219
[4] MAIMONIDES HOSP,DEPT OBSTET & GYNECOL,BROOKLYN,NY 11219
关键词
D O I
10.1016/0090-8258(91)90334-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study evaluates the effects of various prognostic indicators on survival of patients with clinical Stage I endometrial carcinoma. Ninety-three patients who were treated for clinical Stage I endometrial adenocarcinoma at Maimonides Medical Center from October 1979 to October 1987 had sufficient surgical-pathological information for retrospective surgical staging according to the new FIGO classification. Histology was reviewed. A new grade and surgical stage was assigned to each patient in accordance with the recent FIGO guidelines for surgical staging of corpus cancer. Poor prognostic indicators, namely, tumor grade, depth of myometrial invasion, peritoneal cytology, lymph node metastases, and lymphvascular space (LVS) involvement, were correlated with 5-year survival rates. Survival rates were calculated by the life table method. Depth of myometrial invasion, lymph node involvement, and peritoneal cytology had significant statistical correlation with poor survival. Positive finding of each of the prognostic indicators, including LVS involvement, was significantly associated with poor survival (all P < 0.001). The value of these prognostic indicators in early endometrial carcinoma is discussed. © 1991.
引用
收藏
页码:142 / 145
页数:4
相关论文
共 50 条
  • [41] p53 overexpression as a prognostic indicator in endometrial carcinoma
    Ozalp, S
    Yalcin, OT
    Tanir, HM
    Kabukcuoglu, S
    Erol, G
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2003, 24 (3-4) : 275 - 278
  • [42] p53 staining as a prognostic indicator in endometrial carcinoma
    Özsaran, AA
    Türker, S
    Dikmen, Y
    Erhan, Y
    Itil, I
    Terek, C
    Özdemir, N
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1999, 20 (02) : 156 - 159
  • [43] Endocervical involvement in endometrial adenocarcinoma is not prognostically significant and the pathologic assessment of the pattern of involvement is not reproducible
    Zaino, Richard J.
    Abendroth, Catherine
    Yemelyanova, Anna
    Oliva, Esther
    Lim, Diana
    Soslow, Robert
    DeLair, Deborah
    Hagemann, Ian S.
    Montone, Kathleen
    Zhu, Junjia
    GYNECOLOGIC ONCOLOGY, 2013, 128 (01) : 83 - 87
  • [44] DIAGNOSTIC AND PROGNOSTIC-SIGNIFICANCE OF THE MITOTIC INDEX IN ENDOMETRIAL ADENOCARCINOMA
    PIROG, EC
    CZERWINSKI, W
    GYNECOLOGIC ONCOLOGY, 1992, 46 (03) : 337 - 340
  • [45] The utilization of immunohistochemical prognostic factor in endometrial adenocarcinoma:: is it cost effective?
    Gürer, IE
    Simsek, T
    Erdogan, G
    Atalay, E
    Zorlu, CG
    Karaveli, S
    Erman, O
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2000, 21 (02) : 197 - 199
  • [46] Basigin expression as a prognostic indicator in stage I pulmonary adenocarcinoma
    Matsumoto, Toshihide
    Nagashio, Ryo
    Ryuge, Shinichiro
    Igawa, Satoshi
    Kobayashi, Makoto
    Fukuda, Eriko
    Goshima, Naoki
    Ichinoe, Masaaki
    Jiang, Shi-Xu
    Satoh, Yukitoshi
    Masuda, Noriyuki
    Murakumo, Yoshiki
    Saegusa, Makoto
    Sato, Yuichi
    PATHOLOGY INTERNATIONAL, 2018, 68 (04) : 232 - 240
  • [47] Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma
    Rohloff, J
    Zinke, J
    Schoppmeyer, K
    Tannapfel, A
    Witzigmann, H
    Mössner, J
    Wittekind, C
    Caca, K
    BRITISH JOURNAL OF CANCER, 2002, 86 (08) : 1270 - 1275
  • [48] Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma
    J Rohloff
    J Zinke
    K Schoppmeyer
    A Tannapfel
    H Witzigmann
    J Mössner
    C Wittekind
    K Caca
    British Journal of Cancer, 2002, 86 : 1270 - 1275
  • [49] Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma
    Kuebler, Kirsten
    Ayub, Tiyasha H.
    Weber, Sarah K.
    Zivanovic, Oliver
    Abramian, Alina
    Keyver-Paik, Mignon-Denise
    Mallmann, Michael R.
    Kaiser, Christina
    Serce, Nuran Bektas
    Kuhn, Walther
    Rudlowski, Christian
    GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 176 - 183
  • [50] Stage II Endometrial Adenocarcinoma: Patient Characteristics and Prognostic Factors
    Goldman, K. E.
    Graziano, J. M. Hwang
    Kaptein, J. S.
    Katz, T. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E266 - E267